Pleural Effusion, Malignant Clinical Trials

7 recruiting

Pleural Effusion, Malignant Trials at a Glance

7 actively recruiting trials for pleural effusion, malignant are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 1 with 3 trials, with the heaviest enrollment activity in Pittsburgh, Athens, and Bron. Lead sponsors running pleural effusion, malignant studies include Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), David Bartlett, MD, and Affiliated Hospital of Jiangnan University.

Browse pleural effusion, malignant trials by phase

Treatments under study

About Pleural Effusion, Malignant Clinical Trials

Looking for clinical trials for Pleural Effusion, Malignant? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pleural Effusion, Malignant trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pleural Effusion, Malignant clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

Pleural Effusion, MalignantMalignant MesotheliomaMalignant Pleural Effusion+1 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)10 enrolled1 locationNCT07443020
Recruiting
Phase 1

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

Pleural Effusion, MalignantMalignant MesotheliomaMalignant Pleural Effusion+1 more
David Bartlett, MD10 enrolled1 locationNCT07192900
Recruiting

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Pleural Effusion, MalignantAscites, MalignantCarcinoma+4 more
Travera Inc200 enrolled1 locationNCT05461430
Recruiting
Not Applicable

First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.

Pleural Effusion, MalignantMesothelioma, MalignantPleural Effusion+1 more
National and Kapodistrian University of Athens100 enrolled1 locationNCT06946498
Recruiting

Pleural Carcinomatosis Tissue Banking

Pleural Effusion, Malignant
Hospices Civils de Lyon100 enrolled1 locationNCT04844827
Recruiting
Early Phase 1

Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

Pleural Effusion, MalignantPeritoneal Carcinoma MetastaticHER2 Positive Malignancies
Sichuan University18 enrolled1 locationNCT04684459
Recruiting
Phase 1

IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites

Pleural Effusion, Malignant
Affiliated Hospital of Jiangnan University40 enrolled1 locationNCT05268172